世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000031600

慢性疾患管理:治療薬、デバイス技術および世界市場

BCC Research

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

発刊日 2022/04

言語英語

体裁PDF/411ページ

ライセンス/価格411ページ

0000031600

Single
2-5Users
Site License
Enterprise License

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

慢性疾患管理治療薬およびデバイス技術の世界市場は、2021年の3,918億ドルから、2026年までに5,530億ドルに成長し、2021年から2026年までのCAGRは7.1%と予想されます。

レポートの内容

  • 99のデータ表
  • 慢性疾患管理治療薬およびデバイス技術の世界市場の最新情報と分析
  • 2020年のデータ、2021年の推定値、2026年までのCAGR予測による世界市場の動向分析
  • 全体的な市場規模、予測される成長動向、および対応する市場シェア分析を、製品カテゴリ別、疾患の種類別、デリバリー方法別、治療順守別、治療プロバイダー別、地域別に評価、予測
  • 効果的な疾患管理をサポートする高度な無針ドラッグデリバリー技術、診断方法、およびスマートデバイス技術に重点を置いた、慢性疾患および慢性障害の現状への洞察
  • 医薬品および医療機器の規制構造、価格設定および償還構造、市販およびパイプライン製品、市場に影響を与える主要な開発品
  • 主要な合併および買収取引、商業的に実行可能な製品および技術の開発、および業界内の他の戦略的提携
  • Abbott、AbbVie Inc.、Amgen Inc.、Bayer AG、Boston Scientific Corp.、Dr。Reddy's Laboratories Ltd.、F。Hoffmann、GlaxoSmithKline PLC、Johnson&Johnson、Medtronic、Novartis、Sanofi、Pfizer 、タケダなどの主要なグローバル企業のプロフィール

レポート詳細

目次

Chapter- 1: Introduction
Study Goals and Objectives
What's New in the Report?
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Table Summary : Overall Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, Through 2026
Figure Summary : Overall Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, 2019-2026

Chapter- 3: Chronic Diseases and Growing Burden on Economy
Background of Chronic Diseases
Epidemiology and Global Burden
Chronic Disease Types
Tobacco Smoking and Chronic Diseases
Aging, Gender and Chronic Diseases
Current Challenges and Future Directions

Chapter- 4: Impact of COVID-19
Overview
COVID-19 Crisis
Impact on Market for Chronic Diseases Management
Current Outlook

Chapter- 5: Chronic Diseases: Therapeutics
Therapeutics and Chronic Diseases
Clinical Need for Therapeutics
Therapeutics and Cost Burden
Chronic Diseases and Managed Care
Key Marketed and Pipeline Products
Unmet Need
Current Challenges and Future Developments

Chapter- 6: Device Technologies and Applications
Medical Devices and Chronic Disease Management
Clinical and Market Need of Digital Therapeutics
Types of Device Technologies
Key Marketed and R&D/Pipeline Products
Advantages of Chronic Disease Management via Digital Care
Unmet Need
Future Developments for Healthcare and Safety Monitoring
Current Challenges
Future Outlook

Chapter- 7: Chronic Diseases: Treatment Adherence Devices and Applications
Treatment Nonadherence
Market Need for Medication Adherence Systems and Applications
Types of Medication Adherence Systems and Applications
Key Marketed and Pipeline Products
Software and Mobile Application Advantages
Current Challenges
Future Developments

Chapter- 8: Market Size and Growth Analysis
Market Size and Growth Analysis
Market Growth Drivers and Restraints

Chapter- 9: Competitive Landscape
Figure 31 : Global Market Shares of Chronic Disease Management Therapeutics, by Leading Company, 2020
Figure 32 : Global Market Shares of Chronic Disease Management Device Technologies, by Leading Company, 2020

Chapter- 10: Strategies in the Market for Chronic Disease Management
Consolidations
Mergers and Acquisitions
Future Strategic Landscape

Chapter- 11: Regulatory Structure: Pharmaceuticals and Medical Devices
Regulatory Background
Regulatory Systems for Medical Devices by Region
Regulatory Systems for Pharmaceuticals by Region

Chapter- 12: Pricing and Reimbursement: Pharmaceuticals and Medical Devices
Pricing and Reimbursement Background
Pricing and Reimbursement for Medical Devices by Region
Pricing and Reimbursement for Pharmaceuticals by Region

Chapter- 13: Conclusions—Outlook for Chronic Disease Management
Major Developments Influencing the Market
Long-Term Outlook for Chronic Disease Management

Chapter- 14: Company Profiles
Top 25 Major Companies
Other Players

Chapter- 15: Appendix A: List of Acronyms
Table 98 : List of Acronyms Used in Chronic Disease Management

Chapter- 16: Appendix B: Professional Organizations
American Heart Association
American Diabetes Association
American Lung Association
Infectious Diseases Society of America (IDSA)
National Foundation for Infectious Diseases
Center for Drug Evaluation and Research (CDER)
Center for Devices and Radiological Health (CDRH)
Centers for Medicare and Medicaid Services (CMS)
European Databank for Medical Devices (EUDAMED)
Food and Drug Administration (FDA or USFDA)
Hormone Foundation
International Diabetes Federation (IDF)
International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
Network for Excellence in Health Innovation (NEHI)
National Center for Biotechnology Information (NCBI)
National Institute of Aging (NIA)
Pharmaceuticals and Medical Devices Agency (PMDA)
World Cancer Research Fund International
World Health Organization (WHO)

この商品のレポートナンバー

0000031600

TOP